Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0503AB04 asialo-GM1(d18:1/22:0) Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1310.84 C66H122N2O23
LMSP0503AB05 asialo-GM1(d18:1/24:0) Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1338.88 C68H126N2O23
LMSP0503AB07 asialo-GM1(d18:1/24:1(15Z)) Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1336.86 C68H124N2O23
LMSP0503AB06 asialo-GM1(d18:1/26:0) Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1366.91 C70H130N2O23
LMSP0503AB08 asialo-GM1(d18:1/26:1(17Z)) Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1364.89 C70H128N2O23
LMSP0503AA01 asialo-GM2(d18:1/16:0) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1064.7 C54H100N2O18
LMSP0503AA02 asialo-GM2(d18:1/18:0) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1092.73 C56H104N2O18
LMSP0503AA03 asialo-GM2(d18:1/20:0) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1120.76 C58H108N2O18
LMSP0503AA04 asialo-GM2(d18:1/22:0) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1148.79 C60H112N2O18
LMSP0503AA05 asialo-GM2(d18:1/24:0) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1176.82 C62H116N2O18
LMSP0503AA07 asialo-GM2(d18:1/24:1(15Z)) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1174.81 C62H114N2O18
LMSP0503AA06 asialo-GM2(d18:1/26:0) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1204.85 C64H120N2O18
LMSP0503AA08 asialo-GM2(d18:1/26:1(17Z)) GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1202.84 C64H118N2O18
LMSP0503AL01 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1737.94 C80H143N3O37
LMSP0503AM05 GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1704.01 C82H149N3O33
LMSP0503AM01 GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1591.88 C74H133N3O33
LMSP0503AH01 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1737.94 C80H143N3O37
LMSP0503AH03 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1794 C84H151N3O37
LMSP0503AN06 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1407.93 C72H133N3O23
LMSP0503AD01 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1591.88 C74H133N3O33
LMSP0503AJ03 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1444.87 C70H128N2O28
LMSP0503AJ08 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1526.94 C76H138N2O28
LMSP0503AI08 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1510.95 C76H138N2O27
LMSP0503AL07 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1848.05 C88H157N3O37
LMSP0503AN02 GlcNAcbeta1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1295.81 C64H117N3O23
LMSP0503AJ01 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1388.8 C66H120N2O28
LMSP0503AG08 Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1714.03 C84H151N3O32
LMSP0503AI04 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1456.9 C72H132N2O27
LMSP0503AD08 Galbeta1-4GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1730.02 C84H151N3O33
LMSP0503AJ02 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1416.83 C68H124N2O28
LMSP0503AO04 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1513.92 C74H135N3O28
LMSP0503AI03 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1428.87 C70H128N2O27
LMSP0503AG06 Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1716.04 C84H153N3O32
LMSP0503AG04 Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1659.98 C80H145N3O32
LMSP0503AG05 Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1688.01 C82H149N3O32
LMSP0503AG07 Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1686 C82H147N3O32
LMSP0503AH02 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1765.97 C82H147N3O37
LMSP0503AL08 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1876.08 C90H161N3O37
LMSP0503AO08 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1567.97 C78H141N3O28
LMSP0503AC06 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1569.99 C78H143N3O28
LMSP0503AO07 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1539.94 C76H137N3O28
LMSP0503AC05 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1541.95 C76H139N3O28
LMSP0503AO02 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1457.86 C70H127N3O28
LMSP0503AL02 GalNAcbeta1-3Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1765.97 C82H147N3O37
LMSP0503AM06 GalNAcbeta1-3Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1732.04 C84H153N3O33
LMSP0503AE05 GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1541.95 C76H139N3O28
LMSP0503AO03 GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1485.89 C72H131N3O28
LMSP0503AC03 GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1485.89 C72H131N3O28
LMSP0503AI07 Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1482.92 C74H134N2O27
LMSP0503AJ05 Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] 1500.93 C74H136N2O28